AI for Smarter Healthcare
Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating products that empower healthcare providers by optimizing efficiency, improving accuracy, and increasing precision.
Keya Medical has developed solutions for specialties including cardiology, radiology, neurology, pathology, and surgery. Since 2016, we have collaborated with more than 725 hospitals to improve care delivery on a global scale.
DeepVessel FFR* uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary CT angiogram scans. The software reduces unnecessary invasive testing to lower costs and complications.
*CE Marked, National Medical Products Administration (NMPA) Approved. Not for sale in the United States.
CuraRad® – ICH
R&D Pipeline Solutions
Keya Medical is developing a comprehensive R&D pipeline to deliver clinical value throughout the patient care process. The product candidates in our pipeline will be designed for use in early screening, diagnosis, treatment, and post-treatment maintenance.
Deep learning-based CT-FFR has demonstrated potential in improving the diagnosis of patients with coronary artery disease. Learn more about how deep learning-based CT-FFR can help improve patient outcomes in this introductory guide.
The expression “time is brain” has been used to demonstrate the importance of urgency in treating stroke patients. Learn more about how AI can help transform the diagnosis and treatment of stroke patients to improve outcomes.
Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.